TY - JOUR
T1 - CXCL10 haplotypes and multiple sclerosis
T2 - Association and correlation with clinical course
AU - Galimberti, D.
AU - Scalabrini, D.
AU - Fenoglio, C.
AU - Comi, C.
AU - De Riz, M.
AU - Venturelli, E.
AU - Lovati, C.
AU - Mariani, C.
AU - Monaco, F.
AU - Bresolin, N.
AU - Scarpini, E.
PY - 2007/2
Y1 - 2007/2
N2 - CXCL10 (interferon-γ-inducible protein-10) levels are increased in cerebrospinal fluid of multiple sclerosis (MS) patients with symptomatic attacks of inflammatory demyelination, supporting a role for this molecule in MS pathogenesis. Two hundred and twenty-six patients with MS and 235 controls were genotyped for G → C and T → C single nucleotide polymorphisms (SNPs) in exon 4 of CXCL10 gene. Haplotypes were tested for association and correlated with clinical variables. The two SNPs studied were in complete linkage disequilibrium. None of the determined haplotypes was associated with MS. However, carriers of the GGTT haplotype (defined as wild type, according to the sequence in National Centre for Biotechnology Information (NCBI) database) had a significantly lower progression index than non-carriers (P = 0.016). Furthermore, amongst patients who had an initial relapsing remitting (RR) course of the disease, the time between onset and second episode was significantly longer in GGTT carriers (P = 0.021). Considering secondary progressive (SP)-MS patients, the time between the initial RR form and the subsequent worsening to SP was longer in this group (P = 0.08). Therefore, the GGTT haplotype of the CXCL10 gene is not a susceptibility factor for the development of MS, but is probably to influence the course of MS, possibly contributing to slow down the progression of the disease.
AB - CXCL10 (interferon-γ-inducible protein-10) levels are increased in cerebrospinal fluid of multiple sclerosis (MS) patients with symptomatic attacks of inflammatory demyelination, supporting a role for this molecule in MS pathogenesis. Two hundred and twenty-six patients with MS and 235 controls were genotyped for G → C and T → C single nucleotide polymorphisms (SNPs) in exon 4 of CXCL10 gene. Haplotypes were tested for association and correlated with clinical variables. The two SNPs studied were in complete linkage disequilibrium. None of the determined haplotypes was associated with MS. However, carriers of the GGTT haplotype (defined as wild type, according to the sequence in National Centre for Biotechnology Information (NCBI) database) had a significantly lower progression index than non-carriers (P = 0.016). Furthermore, amongst patients who had an initial relapsing remitting (RR) course of the disease, the time between onset and second episode was significantly longer in GGTT carriers (P = 0.021). Considering secondary progressive (SP)-MS patients, the time between the initial RR form and the subsequent worsening to SP was longer in this group (P = 0.08). Therefore, the GGTT haplotype of the CXCL10 gene is not a susceptibility factor for the development of MS, but is probably to influence the course of MS, possibly contributing to slow down the progression of the disease.
KW - CXCL10
KW - Clinical course
KW - Haplotypes
KW - Interferon-γ-inducible protein-10 polymorphisms
KW - Multiple sclerosis
UR - http://www.scopus.com/inward/record.url?scp=33846459353&partnerID=8YFLogxK
U2 - 10.1111/j.1468-1331.2006.01629.x
DO - 10.1111/j.1468-1331.2006.01629.x
M3 - Article
SN - 1351-5101
VL - 14
SP - 162
EP - 167
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 2
ER -